Quietly Triumphant

Yet Mabs remain hidden from public view. This is partly because the history of the technology has often been overshadowed by the groundbreaking and controversial American development of genetic engineering in 1973, which revolutionised the manufacturing and production of natural products such as insulin, and inspired the foundation of Genentech, one of the world’s first biotechnology companies.

Looking back, the oversight is not surprising. Mabs did not transform medicine overnight or with any major fanfare, and the scientists who made the discovery did not seek fame. Instead, Mabs quietly slipped unobserved into everyday healthcare practice.

An Argentinian and a German came together in a British Laboratory and changed the face of medicine forever; their story deserves to be told.

The Conversation

Lara Marks is at University of Cambridge

This article was originally published on The Conversation. Read the original article.